View Article

Abstract

Pharmacovigilance is crucial for gathering reliable data regarding the safety of herbal medicines used in the US and Europe. The current processes, which were developed for synthetic drugs, need to be adjusted to account for the unique characteristics of medicinal herbs. Even basic issues like chemical diversity and herb naming systems appear to be challenging when using traditional medicine from several cultures in these areas. Additionally, because natural or herbal products are inherently harmless, many people see them. Because of the connected tag, the safety monitoring component was overlooked. One significant component of the trend toward alternative medicine is herbal remedies. In the modern world, as more people look for natural medicines, it is growing in popularity. Since the beginning of civilization, these medications have been used to treat and preserve health. To be competitive in the rapidly growing pharmaceutical sector. The development and validation of more herbal products having medicinal efficacy is urgently needed. This analysis provides a synopsis of herbal therapies that aims to demonstrate Pharmacovigilance, which encompasses the standardizing goods for these herbal products.

Keywords

Pharmacovigilance, Herbal Medicine, Standardization, Stability testing, Efficacy.

Introduction

Plants or plant parts are used to make herbal remedies, which are used to heal and prevent injuries, illnesses, and diseases. diseases and ailments, or to promote health and recovery. The plant or plants from which this drug or preparation is made are used in any goals. "The investigation of marketed medications' safety in the real-world circumstances of Pharmacovigilance is defined as "clinical usage in large communities" (Mann and Andrews (2002). The objective is to detect adverse drug reactions and enhance safety monitoring.  that were previously overlooked but have been assessed in clinical investigations. Although these methods were created to monitor prescription drugs, and they are also used for additional evaluation of the safety of other medications, including herbal remedies, blood products, vaccinations. Reports of potential toxicity and unfavorable effects have surged along with the usage of herbal remedies. Such undesired responses may result from (i) side effects, which are often pharmacodynamically observable and frequently predictable); (ii) responses brought on by tolerance, overdosing, addiction, or dependency (which can be identified via pharmacodynamics). or pharmacovigilance); (iv) mid-term and long-term toxic effects, such   as liver, renal, cardiac, and neurotoxicity as well as genotoxicity and teratogenicity (detectable by in vitro and in vivo toxicological studies or by pharmacovigilance); (iii) hypersensitivity, allergic, and idiosyncratic reactions (detectable by pharmacovigilance). Herbal medicines are the oldest known medicinal practice 1, 2, and 3. Herbal medicines are complete, labeled pharmacological products composed of active ingredients, aerial, or parts of the plant or another plant, according to the World Health Organization (WHO).  substances or mixes found underground. Concerns regarding the safety of herbal remedies   have existed for regulatory bodies, as serious adverse consequences as renal failure, hepatotoxicity, and There have been documented allergic reactions. Understanding the growing importance of herbal the use of medications worldwide, the World Health Organization published guidelines for keeping an eye on the safety of herbal remedies using the current pharmacovigilance framework (WHO, 2004).  

Guidelines for evaluating the quality, safety, and effectiveness of herbal medicines have been developed by the World Health Organization (WHO). in order to achieve worldwide harmonization. A yellow card system for ADR reporting has been introduced by the Uks medicines and healthcare products regulatory agencies to track the safety of herbal medicines . Despite efforts to create a strategic plan for its integration, the cameoonian. Drug Regulation Agency (CDRA), like many other nations, especially developing nations, has not yet completely incorporated traditional herbal medicine into all facets of the healthcare system. The Cameroonian herbal regulatory system could use herbal pharmacovigilance to access several aspects of adverse drug reactions (ADRs), acute or delayed toxicity, allergies, and other issues related to formulations containing one or more herbs. In order to accomplish the ultimate goal of giving patients access to safer and more effective treatment, modified spontaneous reporting forms must be created using the WHO template in order to gather data on suspected adverse drug reactions (ADRs) of herbal medications. The goal of this review is to present a critical analytical summary of the current status of national and international pharmacovigilance for herbal medicines in Cameroon.   

Needs:  

  1. It is commonly acknowledged that the clinical development of medications, including herbal medications and their derivatives, is a complicated process. A medication is released from the safe and secure scientific setting of clinical trials and becomes available for use once it is launched. by the people in general. The majority of herbal medications will only have undergone short-term safety and effectiveness testing on a small number of carefully chosen subjects at this time.   
  2. As a result, pharmacovigilance for herbal medications is required. This includes ensuring the early identification of novel adverse events or patient subgroups with unusual sensitivity and implementing specific risk management strategies.   
  3. Furthermore, after being launched, novel and medically developing medicines must be evaluated for efficacy and safety in real-world settings.  
  4. Additionally, more data is typically required about the safety and effectiveness of long-term usage in conjunction with other medications, as well as use in particular population groups such children, pregnant women, and the elderly.  

Pharmacovigilance:  

Objectives: 

  1. The main objectives of pharmacovigilance involve exhibiting the efficacy of drugs by monitoring their adverse effect profile for many years from the lab to the pharmacy; tracking any drastic effects of drugs improving public health and safety in relation to the use of medicines; encouraging the safe, rational and costeffective use of drugs; promoting understanding, education and clinical training in pharmacovigilance; and effective communication to the generic public. 
  2. In addition, providing information to consumers, practitioners and regulators on the effective use of drugs alongwith designing programs and procedures for collecting and analyzing reports from patients and clinicians conclude to the objectives of pharmacovigilance studies. 

Functions: 

Functions of pharmacovigilance, as to WHO Guidelines (2000), include: 

  • Drug quality, safety, and effectiveness are all actively monitored and reported on. 
  • Adverse responses are also found and studied. 
  • Monitoring the effects of any corrective actions taken. 
  • Measuring risk. 
  • Measuring effectiveness.  
  • Evaluating benefits and harms.  
  • Disseminating information, education v Early warning v Rational and safe use of medicines.  
  • Informing consumers, practitioners, and regulators on the effective use of drugs. 
  • Creating programs and procedures for gathering and analyzing reports from patients and clinical. 

Scope:  

The field of pharmacovigilance has made great progress since the WHO technical report from 1972 and is still active today on both the scientific and clinical levels. Getting to know the difficulties presented by the growing diversity and strength of biological and pharmacological treatments, such as immunisations, which include an Unavoidable and sometimes unexpected risk of injury, has become essential. However, there is a reduced risk of harm when using medications by healthcare providers with expertise and by those who understand and take responsibility for their prescription drugs.   

Pharmacovigilance Of Herbal Drugs:  

"The identification, evaluation, and comprehension of drug-related issues or side effects at therapeutic concentrations utilized or meant to be used utilized to alter or investigate the physiological system or pathological conditions for the recipient's benefit "is the phrase "pharmacovigilance" according to the WHO's definition. The regularity of issues with the quality of Unani herbal items, like mislabeled or mistaken plants, inadequate processing methods, and the supply of contaminated or altered products or plants, which has made pharmacovigilance an essential part of this process.     In order to identify the challenges associated with effectively monitoring the security of  herbal medications and developing suitable countermeasures, the National  Pharmacovigilance System was established.  The majority of the negative effects associated with these herbal remedies are caused by either improper or insufficient product use. It is believed that insufficient quality control is the root cause of many undesirable events. system, a feeble regulatory setting. Pharmacovigilance aims to identify, evaluate, comprehend, and prevent any negative effects or any potential drug-related issues associated with herbal, conventional, and complementary therapies. Pharmacovigilance's objectives are to shield patients from avoidable injury by recognizing pharmacological dangers that were previously unknown, clarifying determining risk factors and weighing advantages against risks. Although several well-known herbal security concerns have recently been raised regarding the health of the general public, the use of herbal treatments is widespread in both developed and developing countries. Herbal treatments were once believed to be harmless, despite the fact that they are essential as drugs to ascertain the risks involved. Publicly available data shows that the risk is either to a pollutant or an additional medication. Pharmacovigilance's goal is to identify, evaluate, comprehend, and avoid any negative effects or other potential drug-related issues associated with herbal, conventional and alternative therapies . Although both industrialized and developing nations use herbal medications extensively, there have been a number of high-profile herbal safety issues in recent years that have affected public health. Although herbal remedies are typically thought to be safe, as pharmaceuticals, they must be monitored for any hazards through drug surveillance. According to published statistics, the risk results from either an additional medicine or a contaminant. Very little is known about the components of herbal medications and how they affect people, and there isn't strict quality control and the fact that herbal medications are diverse means that their safety must be continuously monitored. Within the framework of the WHO International Drug Monitoring Program, WHO has stepped up its efforts to support herbal safety monitoring. Herbal medication pharmacovigilance presents unique difficulties since these formulations might be obtained from a variety of outlets where most transactions are made in a traditional over-the-counter setting, usually without a health care expert present.

Challenges Of Herbal Pharmacovigilance: 

Herbal pharmacovigilance is the monitoring of the safety and efficacy of herbal medicines. While herbal medicines have been used for centuries, they are not without risks, and there are several challenges associated with herbal pharmacovigilance, including:  

Lack of standardization:  Because herbal medicines are sometimes not standardized, the active ingredients and their proportions might vary greatly between different product batches, making it difficult to assess the safety and efficacy of the treatments.  

Difficulty in identifying adverse events:  Adverse effects associated with herbal drugs are sometimes underreported or not recognized at all because they are not well understood or recognized. Well understood. This could be quite challenging in populations. where conventional medicine is combined with herbal remedies, making it difficult to determine the cause of adverse events.    Cultural and linguistic barriers: Herbal treatments are commonly used in culturally specific traditional medical systems, and the terminology used to administer these drugs may be complex. comprehensible or recognizable to someone not in the custom. Collecting and evaluating information regarding the efficacy and safety of of natural medications.  Limited regulation: Since herbal medicines are classified as dietary supplements rather than medications, they are typically subject to less stringent regulations than pharmaceuticals. in contrast to prescribed drugs. It might be made possible by this. difficult to ensure the effectiveness and safety of these products. Lack of standardized reporting:  There is no systematic way to report adverse occurrences related to herbal drugs. Information on the effectiveness and safety of these products may be difficult to collect and assess. Generally speaking, pharmacovigilance using Herbs require a multidisciplinary approach and collaboration from multiple stakeholders. stakeholders, including the general public, regulatory agencies, scientists, and medical experts.   

Who Guidelines on Safety Monitoring of Herbal Medicines in Pharmacovigilance Systems:   

The safety of herbal medicines is a serious public health issue. The policy highlights: l The need for protocols for pharmacovigilance systems to keep an eye on the safety of herbal remedies; l Standard definitions of terms used in safety monitoring and pharmacovigilance of natural remedies. 1 Challenges in determining if herbal therapies are effective In effect Good communication is essential to safety monitoring. With the aid of these suggestions, member states will find it easier to control herbal remedies and other products. utilized in conventional medicine. The usage of synthetic drugs prompted the development of the present pharmacovigilance models and methodologies. alterations to existing procedures, patient disclosure, and heightened awareness of pharmacogenetics and pharmacogenomics to optimize the safety of  all have the potential to enhance the safety monitoring of herbal treatments. In order to guarantee the effectiveness, safety, and quality of traditional medicine, there There are no widely accepted standards for quality control or suitable techniques for evaluation.   

The following actions can be taken to put in place an efficient pharmacovigilance system:   

Step 1: Planning the Pharmacovigilance Phase Step.               

Step 2: Establishing a culture of notification.   

Step 3: Debriefing, interaction, and training.   

Step 4: Establishment of reporting methods.   

Step 5: Documenting and identifying the composition of herbal medications.  

 Step 6: Examining the case reports.   

Step 7: Data analysis.   

Step 8: Data handling.  

Step 9: Last reporting to advisory or regulatory committee.  

Step 10: Data upkeep.   

Step 11: Reporters receive feedback.  

Step 12: Sharing risk information among reports, pharmacovigilance canters, UMCs, and the general public.   

Step 13: Information Publication As significant safety information becomes available and milestones are met, the pharmacovigilance plan should be updated often.  

Adverse Drug Reactions:   

  1. Herbal remedies do not entirely eliminate adverse drug reactions. Some adverse drug reactions to common herbs include: St. John's Wort (Hypericum perforatum) causes allergic reactions, gastrointestinal problems, and Ginkgo biloba causes bleeding on its own.  problems, fatigue, lightheadedness, photosensitivity, confusion, Capsicum annuum has the potential to Arrhythmias, cardiac arrest, ephedra, the fruit of the chest tree, and cardiac Liver damage is caused by Vitex agnus, headaches, diarrhea, and Piper methysticum.   
  2. According to Charaka, "if given correctly, even a powerful poison can become an excellent medicine." However, if administered improperly, even the most beneficial medication might become poisonous.  
  3. Since the majority of herbal medications lack clinical studies, post-marketing pharmacovigilance becomes an essential source of safety data. Nonetheless, the evaluation of negative reactions linked to herbal medications provides special issues with the amount and caliber of information that is currently provided.  
  4. Unquestionably, plants have played a significant part in the creation of contemporary medications. Plant products are the direct or indirect source of more than 60–70% of  contemporary medications sold worldwide.  
  5. Well-publicized problems, such adverse drug reactions linked to ephedra and aristolochia, have demonstrated that herbal remedies can be hazardous to people. Hepatic and renal issues are the most often reported side effects. But it's challenging. Because traditional herbal medicines may contain many substances, it is necessary to determine the causal factor linked to the ADRs seen.  

Drug Interactions:   

Procainamide, digoxin, phenytoin, cyclosporine, Warfarin, Theophylline, and other drugs with a narrow therapeutic range should discourage most people from using herbal products. All-purpose drugs with a narrow therapeutic spectrum could be less effective or have more negative effects when mixed with herbal products. Ginkgo is used to treat Alzheimer's disease and increases bleeding when combined with aspirin. illness.Ginseng has many uses and works in concert with inhibitors of monoamine oxidase. Kava is used as a relaxing herb and shows alignment with benzodiazepines.  

 

Pharmacokinetic Interaction: (quantitive alteration)  

  1. Absorption of drug   
  2. Distribution of drug  
  3. Metabolism and bioavailability of drug   
  4. Elimination (renal and hepatic) of drug   

Pharmacodynamic Interaction:  

  1. Antagonistic effect   
  2. Additive effect   
  3. Synergistic effect  
  4. Potentiation  

Herb–Drug Interaction:  

Few studies that have been done in which herb-drug interaction has shown some changes in the pharmacokinetics as well as pharmacodynamics of the drugs are given below:  

 

Ephedra +antidepressants

Elevanted blood pressure / heart rate

Garlic + ginger + warfarin

Increase bleeding

Carica papaya (extract) + warfarin

Increase international normalised ratio

(INR)

Liquorice + oral contraceptive

Increased hypersensitivity

Liquorice + Digoxin

Increased effect of cardiac glycoside

Tamarind + aspirin

Increased bioavailability of aspirin

Jujube + indomethacin

Increased bioavailability of indomethacin

Psoralia seed + tetracylin

Causes photo allergy

Standardization of Herbal Medicines:   

Manufacturers could utilize standardization as a rule of behavior to guarantee constant efficacy and batch-to-batch consistency. among their offerings. Herbal standardized products are a challenging procedure because the herbs ingredients intricate combinations of many ingredients or Herbal blends are occasionally utilized as common in many medical systems, including like Ayurveda. In these situations, the precise element Some herbal that are said to have the desired benefits are not sure. The most important aspect in standardization is structure elucidation and validation of markers using physicochemical properties such as melting point, boiling point, optical rotation and other pre-formulation data followed by the use of IR, NMR, MS and other highly sophisticated analytical methods. GMP should also be applied to the quality monitoring of herbal medications. GMP practices ought to created for the safety of herbal medicine, identity, potency, clarity, and excellence of herbal medicines. The standard of herbal remedies is determined by about the evaluation of raw plant material. The safety of herbal medicines is based on the toxicological studies. The efficacy of the herbal medicines is based on the pharmacological and clinical effects of the active ingredients. Quantitative and qualitative standardization of a polyherbal product may be done by using the instrumental analysis or by means of chromatography.  

Stability Testing of Herbal Medicines:  

Testing for stability in herbal medications presents a difficult risk because the whole herb or herbal product is recognized as the active ingredient, irrespective of if ingredients having specific medicinal activities are recognized. The objective of a stability testing is to provide evidence on how the quality of the herbal products varies with the time under the influence of environmental factors such as temperature, light, oxygen, moisture, other ingredient or excipient in the dosage form, particle size of drug, microbial contamination, trace metal contamination, leaching from the container and to establish a recommended storage condition and shelf-life. To guarantee that the product is of a suitable quality for the duration of its storage, stability testing is required. stability studies ought to be carried out on three or more manufacturing batches of the herbal goods for the suggested duration of use, which is used to indicate steadiness over the long run and is carried out in an ambient that is natural.  

ADVANTAGES:  

  1. affordable and easily accessible. A licensed naturopath should always administer controlled amounts of high-quality herbs. 
  2. Natural healing. 
  3. reduced chance of adverse effects. 
  4. You can experiment with various herbs without risk. 

DISADVANTAGES:  

  1. allergic reactions and rashes. 
  2. asthma. 
  3. headaches. 
  4. nausea. 
  5. vomiting. 
  6. diarrhea 

CONCLUSION:  

The use of medicinal herbs as a possible source of therapeutic help has grown significantly in the global health care system. world for humans as potential resources for preserving good health as well as in the state of illness . It is evident that the herbal sector has enormous potential for global growth. Given the growing popularity of herbal products, quality considerations should be sufficiently covered by future global labeling standards.  To comprehend the use of herbal medications, standardization of procedures and quality control data on safety and efficacy are necessary. Lack of knowledge about the medical plant-based industries has been a significant barrier to their growth in developing nations. advantages for society and the economy that could result from using medicinal herbs in industry . To fully use the chemicals causing the reported biological action, more investigation is needed.   the significance of ongoing watchfulness in guaranteeing the security of herbal medications. The absence of clear reporting procedures for herbal remedies presents a problem for recognizing and reporting adverse events since there isn't a standardized way to do so. Because patients and healthcare professionals could be reluctant or ignorant of the connection between using herbal drugs and adverse events, this could result in underreporting of adverse events.   Patients and healthcare providers should be aware of the possibility of herbal medicine interactions with herbal products, and further study is required to comprehend their clinical consequences and mechanics. The lack of adequate quality control, monitoring, and unregulated distribution of herbal medications results in minimal reports of adverse drug responses to regulatory bodies.

REFRENCES

        1. WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems”, World Health Organization, Geneva. 2004. 
        2. Mosihuzzaman M, Choudhary M I. Protocols on safety, efficacy, standardization, and documentation of herbal medicine (IUPAC Technical Report). Pure Appl. Chem., 2008;80(10):2195-230.  
        3. Bensoussan A, Myers SP. Towards a Safer Choice: The Practice of Traditional Chinese Medicine in Australia. Faculty of Health, University of Western Sydney, Macarthur. 1996.  
        4. Awodele O, Daniel A, Popoola TD, Salami EF. A study on pharmacovigilance of herbal medicines in Lagos West Senatorial District, Nigeria. Int J Risk Saf Med. 2013;25(4):20517. 
        5. Zhang L, Wong YL, He Y et al (2014) Pharmacovigilance in China: current situation, successes and challenges. Drug Saf 37 (10):765–770. https://doi.org/10.1007/ s402640140222- 3 
        6. UMC (2000) Safety monitoring of medicinal products. https://www.whoumc.org/media/ 1703/24747.pdf. Accessed 23 Jun 2017 
        7. 4. WHO technical report series, Guidelines for the assessment of herbal medicines, 863, 1996, 178-184.  
        8. Abhishek K, Ashutosh M, Sinha BN, Herbal drugspresent status and efforts to promote and regulate cultivation, The Pharma Review, 6,2006, 73-77.  
        9. Harish P, Herbal drugs, Current Science, 81(1), 2001, 15. 
        10. Coleman LM, Fowler LL, Williams ME, Use of unproven therapies by people with Alzheimer’s disease, Journal of the American Geriatrics Society, 43, 1995, 747-750. 
        11. Kuhn MA, Herbal remedies: drug-herb interactions, Critical Care Nurse, 22, 2002, 2232. 
        12. Hussin AH, Adverse effects of herbs and drug herbal interactions,Malaysian Journal of Pharmacy, 1, 2001, 39- 44. 
        13. Chauhan VS, Standardizing herbs and intermediatesnewer approaches,The Pharma Review, 2, 2006, 37-44.  
        14. Wani MS, Parakh SR, Dehghan MH, Herbal medicines and its standardization,Pharmainfo.net, 5(6), 2007.  
        15. Chakravarthy BK, Standardization of herbal products, Indian Journal of Natural Products, 9, 1993, 23-26.  
        16. Sane RT, Standardization, quality control and GMP for herbal drugs, Indian Drugs, 39(3), 2002, 184-190.  
        17. Rawat RK, Khar RK, Garg A, Development and standardization of herbal formulations, The Pharma Review, 6, 2007, 104. 
        18. Thakur AK, Prasad NAV, Ladha KS, Stability testing of herbal products, The Pharma Review, 4, 2008, 109-112.  
        19. Kathrin K, Eike R, Anne B, Validation of standardized high performance thin layer chromatographic methods for quality and stability testing of medicines, Journal of AOAC International, 86(5), 2003,909-915. 
        20. Manoj S, Raman S, Gupta VB, Chatterjee A, Pharmacovigilance of herbal medicines, The Pharma Review, 12, 2006, 119-124. 
        21. Safety monitoring of medicinal products: guidelines for setting up and running a pharmacovigilance centre. Uppsala, Uppsala Monitoring Centre, 2000 (reproduced in Part II of this publication).  
        22. US report calls for tighter controls on complementary medicine. Br Med J. 2002;324:870.  
        23. Three out of four Germans have used complementary or natural remedies. Br Med J. 2002;325:990.  
        24. Geneva: World Health Organization; 2000. General guidelines for methodologies on research and evaluation of traditional medicine. (WHO/EDM/TRM/2000.1)  
        25. Safety monitoring of medicinal products. Geneva: World Health Organization; 2002. The importance of pharmacovigilance. 
        26. Ackernecht, E.H., Therapeutics from the Primitives to the Twentieth Century. Hafner Press, New York, 1973.  
        27. Gossell, M., Simon, O.R., West, M.E., The past and the present use of plants for medicines. West Indian Medical Journal, 2006, 55:217. 
        28. Safety monitoring of medicinal products: guidelines for setting up and running a pharmacovigilance centre. Uppsala, Uppsala Monitoring Centre, 2000 (reproduced in Part II of this publication). 
        29. Mann, R.D., Andrews, E.F. (Eds.), 2002. Pharmacovigilance. Wiley, Chichester. 
        30. Gupta YK. Ensuring patient safety— launching the new pharmacovigilance programme of India. Pharma Times. 2010;42(8):21–6

Reference

  1. WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems”, World Health Organization, Geneva. 2004. 
  2. Mosihuzzaman M, Choudhary M I. Protocols on safety, efficacy, standardization, and documentation of herbal medicine (IUPAC Technical Report). Pure Appl. Chem., 2008;80(10):2195-230.  
  3. Bensoussan A, Myers SP. Towards a Safer Choice: The Practice of Traditional Chinese Medicine in Australia. Faculty of Health, University of Western Sydney, Macarthur. 1996.  
  4. Awodele O, Daniel A, Popoola TD, Salami EF. A study on pharmacovigilance of herbal medicines in Lagos West Senatorial District, Nigeria. Int J Risk Saf Med. 2013;25(4):20517. 
  5. Zhang L, Wong YL, He Y et al (2014) Pharmacovigilance in China: current situation, successes and challenges. Drug Saf 37 (10):765–770. https://doi.org/10.1007/ s402640140222- 3 
  6. UMC (2000) Safety monitoring of medicinal products. https://www.whoumc.org/media/ 1703/24747.pdf. Accessed 23 Jun 2017 
  7. 4. WHO technical report series, Guidelines for the assessment of herbal medicines, 863, 1996, 178-184.  
  8. Abhishek K, Ashutosh M, Sinha BN, Herbal drugspresent status and efforts to promote and regulate cultivation, The Pharma Review, 6,2006, 73-77.  
  9. Harish P, Herbal drugs, Current Science, 81(1), 2001, 15. 
  10. Coleman LM, Fowler LL, Williams ME, Use of unproven therapies by people with Alzheimer’s disease, Journal of the American Geriatrics Society, 43, 1995, 747-750. 
  11. Kuhn MA, Herbal remedies: drug-herb interactions, Critical Care Nurse, 22, 2002, 2232. 
  12. Hussin AH, Adverse effects of herbs and drug herbal interactions,Malaysian Journal of Pharmacy, 1, 2001, 39- 44. 
  13. Chauhan VS, Standardizing herbs and intermediatesnewer approaches,The Pharma Review, 2, 2006, 37-44.  
  14. Wani MS, Parakh SR, Dehghan MH, Herbal medicines and its standardization,Pharmainfo.net, 5(6), 2007.  
  15. Chakravarthy BK, Standardization of herbal products, Indian Journal of Natural Products, 9, 1993, 23-26.  
  16. Sane RT, Standardization, quality control and GMP for herbal drugs, Indian Drugs, 39(3), 2002, 184-190.  
  17. Rawat RK, Khar RK, Garg A, Development and standardization of herbal formulations, The Pharma Review, 6, 2007, 104. 
  18. Thakur AK, Prasad NAV, Ladha KS, Stability testing of herbal products, The Pharma Review, 4, 2008, 109-112.  
  19. Kathrin K, Eike R, Anne B, Validation of standardized high performance thin layer chromatographic methods for quality and stability testing of medicines, Journal of AOAC International, 86(5), 2003,909-915. 
  20. Manoj S, Raman S, Gupta VB, Chatterjee A, Pharmacovigilance of herbal medicines, The Pharma Review, 12, 2006, 119-124. 
  21. Safety monitoring of medicinal products: guidelines for setting up and running a pharmacovigilance centre. Uppsala, Uppsala Monitoring Centre, 2000 (reproduced in Part II of this publication).  
  22. US report calls for tighter controls on complementary medicine. Br Med J. 2002;324:870.  
  23. Three out of four Germans have used complementary or natural remedies. Br Med J. 2002;325:990.  
  24. Geneva: World Health Organization; 2000. General guidelines for methodologies on research and evaluation of traditional medicine. (WHO/EDM/TRM/2000.1)  
  25. Safety monitoring of medicinal products. Geneva: World Health Organization; 2002. The importance of pharmacovigilance. 
  26. Ackernecht, E.H., Therapeutics from the Primitives to the Twentieth Century. Hafner Press, New York, 1973.  
  27. Gossell, M., Simon, O.R., West, M.E., The past and the present use of plants for medicines. West Indian Medical Journal, 2006, 55:217. 
  28. Safety monitoring of medicinal products: guidelines for setting up and running a pharmacovigilance centre. Uppsala, Uppsala Monitoring Centre, 2000 (reproduced in Part II of this publication). 
  29. Mann, R.D., Andrews, E.F. (Eds.), 2002. Pharmacovigilance. Wiley, Chichester. 
  30. Gupta YK. Ensuring patient safety— launching the new pharmacovigilance programme of India. Pharma Times. 2010;42(8):21–6

Photo
Kalyani Nikam
Corresponding author

S.N.D College of Pharmacy Babhulgaon Yeola.

Photo
Dhanashri Pawar
Co-author

S.N.D College of Pharmacy Babhulgaon Yeola.

Photo
Sakshi Shinde
Co-author

S.N.D College of Pharmacy Babhulgaon Yeola.

Kalyani Nikam*, Dhanashri Pawar, Sakshi Shinde, Review on Pharmacovigilance of Herbal Medicine, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 3, 1946-1956. https://doi.org/10.5281/zenodo.15056988

More related articles
Reviewing Herbal Remedies for Managing Anxiety and...
Aman Upaganlawar, Chandrashekhar Upasani, Manojkumar Mahajan, Puj...
Curcumin Phytosomes: A Promising Nanocarrier Syste...
Nikhil Khopade, Kakasaheb kore, Sucheta bhise, Adinath bhusari, D...
Herbal Drugs In Parkinson Disease...
Wasif Rao, Bishal Singh, Mohd Asad, Vipul Gupta , Shivani Pegowal...
Harmonizing Tulsi: The Quest For Standardization...
Prerna Sharma, Satish Kumar Sharma, ...
Polyherbal Churn For Treatment Of Diabetes...
Tushar Sanjay Bochare, Nishan Bobade , Vedant Sanjay Ganorkar , Vaishnavi Chavhan, Ashweeni Kedar, ...
Related Articles
Innovative and Alternative Approaches to Urticaria Management...
Krunal K. Detholia, Mukesh B. Jadeja, Umang R. Varia, Hitesh B. Katariya, Vidhi D. Panchal, Vishal B...
Artificial Intelligence in Pharmacovigilance...
Shubhangi Dukare, Priti Pokharkar, Ganesh Lamkhade, Aditi Pawar, Vinit Bankar, ...
Effective Communication In Pharmacovigilance...
Prajakta Pujari , Sonali Magdum, Kajal Shinde, Darshani Taral, Prajakta Chaugule, Sadhana Pujari, Ra...
Reviewing Herbal Remedies for Managing Anxiety and Depression...
Aman Upaganlawar, Chandrashekhar Upasani, Manojkumar Mahajan, Puja Suryawanshi, Sumitkumar Sharma, R...
More related articles
Reviewing Herbal Remedies for Managing Anxiety and Depression...
Aman Upaganlawar, Chandrashekhar Upasani, Manojkumar Mahajan, Puja Suryawanshi, Sumitkumar Sharma, R...
Curcumin Phytosomes: A Promising Nanocarrier System for Enhancing Bioavailabilit...
Nikhil Khopade, Kakasaheb kore, Sucheta bhise, Adinath bhusari, Dr. Rajkumar Shete , ...
Herbal Drugs In Parkinson Disease...
Wasif Rao, Bishal Singh, Mohd Asad, Vipul Gupta , Shivani Pegowal, ...
Reviewing Herbal Remedies for Managing Anxiety and Depression...
Aman Upaganlawar, Chandrashekhar Upasani, Manojkumar Mahajan, Puja Suryawanshi, Sumitkumar Sharma, R...
Curcumin Phytosomes: A Promising Nanocarrier System for Enhancing Bioavailabilit...
Nikhil Khopade, Kakasaheb kore, Sucheta bhise, Adinath bhusari, Dr. Rajkumar Shete , ...
Herbal Drugs In Parkinson Disease...
Wasif Rao, Bishal Singh, Mohd Asad, Vipul Gupta , Shivani Pegowal, ...